Resistance to Targeted Therapies Against Adult Brain Cancers

Häftad, Engelska, 2018

Del i serien Resistance to Targeted Anti-Cancer Therapeutics

2 089 kr

Beställningsvara. Skickas inom 5-8 vardagar. Fri frakt över 249 kr.

Beskrivning

The volume will include information on the repurposing of drugs in an attempt to circumvent drug resistance, use of small molecule inhibitors in GBM treatment, mechanisms of secondary brain metastasis, drug resistance, and state-of-the-art imaging of targeted therapies.

Produktinformation

Utgivningsdatum:2018-07-04
Mått:155 x 235 x undefined mm
Vikt:423 g
Format:Häftad
Språk:Engelska
Serie:Resistance to Targeted Anti-Cancer Therapeutics
Antal sidor:260
Förlag:Springer International Publishing AG
ISBN:9783319835310

Utforska kategorier

Onkologi inom Medicin
Rättsmedicin inom Medicin

Mer om författaren

Amanda Tivnan, PhD, is Senior Postdoctoral Research Fellow, Department of Physiology and Medical Physics, The Royal College of Surgeons, Dublin, Ireland.

Recensioner i media

“This is a complete monograph on the molecular and cell biology of 'brain tumors' resistant mechanisms. The book discusses chemotherapy and radiotherapy of brain malignancies including gliomas, ependynomas, and meningiomas. … I highly recommend this book as a reference and research tool for neurosurgeons, oncologists, neurologists, residents, and students.” (Joseph Grenier, Amazon.de, May, 2018)

Innehållsförteckning

Targeted therapies in gliomas: An overview.- Targeting chemotherapy resistance in glioblastoma through modulation of ABC transporters.- Resistance of Glioblastomas to Radiation Therapy.- The blood-brain barrier in glioblastoma multiforme: Pathology and therapeutic implications.- Resistance of brain tumours to small-molecule targeted therapies: lessons from various cancer types.- Drug repurposing to circumvent chemotherapy resistance in brain tumours.- Small molecule inhibitors in glioblastoma: Key pathways and resistance mechanisms.- Imaging Targeted Therapy Response and Resistance in Glioblastoma.- Drug Resistance in Malignant Meningiomas.- Recurrence of Low-Grade Glioma - Have the Targeted Therapies Improved for Better Outcomes?.- Host-Tumor Interactions in Brain Cancer Metastasis Leading to Drug Resistance.